查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1721440

医药合约包装市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Pharmaceutical Contract Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 185 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球医药合约包装市场价值为 171 亿美元，预计到 2034 年将以 7.8% 的复合年增长率增长，达到 359 亿美元。整个製药业的快速转型正在显着影响药品的包装和运送方式。随着个人化治疗需求的不断增长和生物技术创新的进步，製药商越来越多地转向专业的合约包装供应商来满足不断变化的需求。随着药物开发变得更有针对性，小批量生产越来越受到关注，包装解决方案必须灵活、合规，并且能够处理多种剂型和敏感配方。

医药合约包装市场 - IMG1

合约包装合作伙伴透过提供符合不断变化的监管框架、增强的可追溯性要求和不断发展的以患者为中心的护理模式的可扩展服务发挥关键作用。药品生产和分销的全球影响力不断扩大，进一步凸显了简化包装流程的必要性，以确保国际市场的安全性、品质和监管一致性。数位转型与自动化和智慧包装工具相结合，正在提高效率，同时加强整个供应链的安全性。随着永续性成为主要优先事项，公司也在整合环保材料，以在不影响性能的情况下减少对环境的影响。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 171亿美元
预测值 359亿美元
复合年增长率 7.8%

预计二次包装领域将大幅成长，到 2034 年预计将达到 143 亿美元。序列化需求、防篡改功能和资讯标籤正在推动对先进二次包装服务的需求成长。智慧包装形式正在成为一种首选，尤其是对于处方药和非处方药，因为它们能够透过二维码和数位介面进行即时验证并增强患者参与度。按照全球绿色包装倡议，再生纸板、环保油墨和水性涂料正受到越来越多的关注，尤其是在旨在提高永续性和最终用户可访问性的二次包装应用中。

预计到 2034 年，药品合约包装领域的塑胶部分将产生 100 亿美元的产值。塑胶以其成本效益和出色的阻隔性能而闻名，仍然是各种药物製剂中的主要材料。然而，日益增长的环境问题正在引导市场转向可生物降解和可回收的塑胶。作为回应，合约包装供应商正在开发下一代塑料解决方案，例如轻质生物基材料和高阻隔生物塑料，以保持产品完整性并支持永续发展目标。

在严格的监管标准和不断发展的序列化要求的推动下，美国医药合约包装市场在 2024 年创造了 53 亿美元的收入。 《药品供应链安全法案》（DSCSA）的实施促进了单位级可追溯性、区块链整合和智慧标籤技术的自动化。生物製剂、基因和细胞疗法以及温度敏感药物的成长正在推动服务提供者加强冷链包装基础设施以满足需求。

全球医药合约包装市场的知名参与者包括 Ameripac、Amcor、Baxter Biopharma Solutions、Adare Pharma Solutions 和 Catalent Pharma Solutions。该公司正在利用自动化、序列化和智慧包装技术（如 NFC 和 QR）来提高合规性、可追溯性和用户互动性。与医药开发商的早期合作以及对永续材料的重视正在帮助合约包装商提供客製化的、面向未来的包装解决方案。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 製药业蓬勃发展
      • 对生物技术和特种药物的需求不断增长
      • 临床试验和小批量包装的增加
      • 对永续包装的需求不断增加
      • 更加重视序列化与防伪
    • 产业陷阱与挑战
      • 初始投资和营运成本高
      • 激烈的竞争和价格压力
  • 成长潜力分析
  • 监管格局
  • 技术格局
  • 未来市场趋势
  • 差距分析
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章：市场估计与预测：依类型，2021-2034

  • 主要趋势
  • 初级包装
    • 瓶子和罐子
    • 小瓶
    • 安瓿
    • 泡罩包装
    • 预充式註射器
    • 其他的
  • 二次包装
  • 三级包装

第六章：市场估计与预测：依材料，2021-2034

  • 主要趋势
  • 塑胶
  • 玻璃
  • 纸和纸板
  • 铝
  • 其他的

第七章：市场估计与预测：依形式类型，2021-2034

  • 主要趋势
  • 口服
  • 注射剂
  • 其他的

第八章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋

第九章：公司简介

  • Adare Pharma Solutions
  • Amcor
  • Ameripac
  • Baxter Biopharma Solutions
  • Catalent Pharma Solutions
  • Daito Pharmaceutical
  • Gracure Pharmaceutical
  • MJS Packaging
  • Nipro
  • Patheon
  • Pharma Packaging Solutions
  • Schott
  • Sharp
  • Sonic Packaging Industries
  • West Pharmaceutical Services
  • WestRock
  • Zoic Biotech
简介目录
Product Code: 13460

The Global Pharmaceutical Contract Packaging Market was valued at USD 17.1 billion in 2024 and is estimated to grow at a CAGR of 7.8% to reach USD 35.9 billion by 2034. Rapid transformations across the pharmaceutical sector are significantly influencing the way medications are packaged and delivered. With rising demand for personalized therapies and advancements in biotech innovation, pharmaceutical manufacturers are increasingly turning to specialized contract packaging providers to address evolving needs. As drug development becomes more targeted and small-batch production gains traction, packaging solutions must be agile, compliant, and capable of handling diverse dosage forms and sensitive formulations.

Pharmaceutical Contract Packaging Market - IMG1

Contract packaging partners are playing a pivotal role by offering scalable services that align with shifting regulatory frameworks, heightened traceability demands, and growing patient-centric care models. The expanding global footprint of pharmaceutical production and distribution further underscores the need for streamlined packaging processes that ensure security, quality, and regulatory alignment across international markets. Digital transformation, coupled with automation and smart packaging tools, is elevating efficiency while reinforcing safety throughout the supply chain. As sustainability becomes a major priority, companies are also integrating eco-conscious materials to reduce environmental impact without compromising performance.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$17.1 Billion
Forecast Value$35.9 Billion
CAGR7.8%

The secondary packaging segment is anticipated to witness substantial growth, with expectations to reach USD 14.3 billion by 2034. Serialization mandates, tamper-proof features, and informative labeling are fueling the rise in demand for advanced secondary packaging services. Smart packaging formats are becoming a preferred choice, especially for prescription and over-the-counter medications, as they enable real-time verification and enhanced patient engagement through QR codes and digital interfaces. In line with global green packaging initiatives, recycled cartonboard, eco-friendly inks, and water-based coatings are gaining traction, especially in secondary packaging applications designed for improved sustainability and end-user accessibility.

The plastic segment in the pharmaceutical contract packaging space is projected to generate USD 10 billion by 2034. Known for its cost efficiency and excellent barrier properties, plastic remains a dominant material across a wide range of drug formulations. However, increasing environmental concerns are steering the market toward biodegradable and recyclable plastics. In response, contract packaging providers are developing next-generation plastic solutions, such as lightweight bio-based materials and high-barrier bioplastics that maintain product integrity while supporting sustainability goals.

United States Pharmaceutical Contract Packaging Market generated USD 5.3 billion in 2024, driven by stringent regulatory standards and evolving serialization requirements. The implementation of the Drug Supply Chain Security Act (DSCSA) has encouraged unit-level traceability, blockchain integration, and automation of smart labeling technologies. Growth in biologics, gene and cell therapies, and temperature-sensitive drugs is pushing service providers to enhance cold chain packaging infrastructure to meet demand.

Notable players in the Global Pharmaceutical Contract Packaging Market include Ameripac, Amcor, Baxter Biopharma Solutions, Adare Pharma Solutions, and Catalent Pharma Solutions. Companies are leveraging automation, serialization, and smart packaging technologies such as NFC and QR to improve compliance, traceability, and user interaction. Early-stage collaboration with pharmaceutical developers and an emphasis on sustainable materials are helping contract packagers deliver customized, future-ready packaging solutions.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing pharmaceutical industry
      • 3.2.1.2 Growing demand for biotechnology and specialty drugs
      • 3.2.1.3 Increase in clinical trials & small-batch packaging
      • 3.2.1.4 Increasing demand for sustainable packaging
      • 3.2.1.5 Increased focus on serialization & anti-counterfeiting
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High initial investment & operational costs
      • 3.2.2.2 Intense competition & price pressure
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates & Forecast, By Type, 2021-2034 (USD Billion)

  • 5.1 Key trends
  • 5.2 Primary packaging
    • 5.2.1 Bottles & jars
    • 5.2.2 Vials
    • 5.2.3 Ampoules
    • 5.2.4 Blister packs
    • 5.2.5 Prefilled syringes
    • 5.2.6 Others
  • 5.3 Secondary packaging
  • 5.4 Tertiary packaging

Chapter 6 Market Estimates & Forecast, By Material, 2021-2034 (USD Billion)

  • 6.1 Key trends
  • 6.2 Plastic
  • 6.3 Glass
  • 6.4 Paper & paperboard
  • 6.5 Aluminium
  • 6.6 Others

Chapter 7 Market Estimates & Forecast, By Form Type, 2021-2034 (USD Billion)

  • 7.1 Key trends
  • 7.2 Oral
  • 7.3 Injectable
  • 7.4 Others

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 (USD Billion)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Adare Pharma Solutions
  • 9.2 Amcor
  • 9.3 Ameripac
  • 9.4 Baxter Biopharma Solutions
  • 9.5 Catalent Pharma Solutions
  • 9.6 Daito Pharmaceutical
  • 9.7 Gracure Pharmaceutical
  • 9.8 MJS Packaging
  • 9.9 Nipro
  • 9.10 Patheon
  • 9.11 Pharma Packaging Solutions
  • 9.12 Schott
  • 9.13 Sharp
  • 9.14 Sonic Packaging Industries
  • 9.15 West Pharmaceutical Services
  • 9.16 WestRock
  • 9.17 Zoic Biotech